542 related articles for article (PubMed ID: 27291759)
1. Pathways of the Maillard reaction under physiological conditions.
Henning C; Glomb MA
Glycoconj J; 2016 Aug; 33(4):499-512. PubMed ID: 27291759
[TBL] [Abstract][Full Text] [Related]
2. Targeting advanced glycation with pharmaceutical agents: where are we now?
Borg DJ; Forbes JM
Glycoconj J; 2016 Aug; 33(4):653-70. PubMed ID: 27392438
[TBL] [Abstract][Full Text] [Related]
3. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").
Miyata T
Bull Mem Acad R Med Belg; 2002; 157(3-4):189-96; discussion 196-8. PubMed ID: 12508715
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products in uremia.
Henle T; Miyata T
Adv Ren Replace Ther; 2003 Oct; 10(4):321-31. PubMed ID: 14681861
[TBL] [Abstract][Full Text] [Related]
5. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia.
Monnier VM; Sell DR; Nagaraj RH; Miyata S; Grandhee S; Odetti P; Ibrahim SA
Diabetes; 1992 Oct; 41 Suppl 2():36-41. PubMed ID: 1526333
[TBL] [Abstract][Full Text] [Related]
6. Fragmentation pathways during Maillard-induced carbohydrate degradation.
Smuda M; Glomb MA
J Agric Food Chem; 2013 Oct; 61(43):10198-208. PubMed ID: 23425499
[TBL] [Abstract][Full Text] [Related]
7. Extending the spectrum of α-dicarbonyl compounds in vivo.
Henning C; Liehr K; Girndt M; Ulrich C; Glomb MA
J Biol Chem; 2014 Oct; 289(41):28676-88. PubMed ID: 25164824
[TBL] [Abstract][Full Text] [Related]
8. Role of the Maillard reaction in diabetes mellitus and diseases of aging.
Thorpe SR; Baynes JW
Drugs Aging; 1996 Aug; 9(2):69-77. PubMed ID: 8820792
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation endproducts in food and their effects on health.
Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs).
Teodorowicz M; Hendriks WH; Wichers HJ; Savelkoul HFJ
Front Immunol; 2018; 9():2088. PubMed ID: 30271411
[TBL] [Abstract][Full Text] [Related]
11. Effect of diet-derived advanced glycation end products on inflammation.
Kellow NJ; Coughlan MT
Nutr Rev; 2015 Nov; 73(11):737-59. PubMed ID: 26377870
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis.
Pinto RS; Machado UF; Passarelli M
Biomark Med; 2020 Jun; 14(8):611-614. PubMed ID: 32530293
[No Abstract] [Full Text] [Related]
13. Novel α-Oxoamide Advanced-Glycation Endproducts within the N
Baldensperger T; Jost T; Zipprich A; Glomb MA
J Agric Food Chem; 2018 Feb; 66(8):1898-1906. PubMed ID: 29436827
[TBL] [Abstract][Full Text] [Related]
14. Food Processing: The Influence of the Maillard Reaction on Immunogenicity and Allergenicity of Food Proteins.
Teodorowicz M; van Neerven J; Savelkoul H
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28777346
[TBL] [Abstract][Full Text] [Related]
15. Dietary advanced glycation end products (dAGEs): An insight between modern diet and health.
Tian Z; Chen S; Shi Y; Wang P; Wu Y; Li G
Food Chem; 2023 Jul; 415():135735. PubMed ID: 36863235
[TBL] [Abstract][Full Text] [Related]
16. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
[TBL] [Abstract][Full Text] [Related]
17. Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology.
Treweek JB; Dickerson TJ; Janda KD
Acc Chem Res; 2009 May; 42(5):659-69. PubMed ID: 19275211
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation in diabetes, aging and age-related diseases: conclusions.
Monnier VM; Taniguchi N
Glycoconj J; 2016 Aug; 33(4):691-2. PubMed ID: 27421862
[No Abstract] [Full Text] [Related]
19. Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo.
Henning C; Smuda M; Girndt M; Ulrich C; Glomb MA
J Biol Chem; 2011 Dec; 286(52):44350-6. PubMed ID: 22069309
[TBL] [Abstract][Full Text] [Related]
20. Protein Repair from Glycation by Glyoxals by the DJ-1 Family Maillard Deglycases.
Mihoub M; Abdallah J; Richarme G
Adv Exp Med Biol; 2017; 1037():133-147. PubMed ID: 29147907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
